The EXCEL Registry of Patients Requiring ECMO
The EXCEL Registry: A Comprehensive Binational Registry on the Treatment and Outcomes of Patients Requiring ECMO
1 other identifier
observational
3,000
2 countries
29
Brief Summary
ECMO is associated with significant costs, risks and requires specialist training and expertise. EXCEL is a novel, high-quality, detailed prospective registry of patients requiring ECMO in Australia and New Zealand. The registry provides information on patient selection, complications, costs and patient reported outcome measures. EXCEL uses the Theoretical Domains Framework to identify evidence-practice gaps and explore barriers and enablers to tailor implementation of evidence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
Longer than P75 for all trials
29 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 15, 2023
September 1, 2023
7.9 years
December 17, 2018
September 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disability-free survival at 6 months, defined as alive and free of disability, measured with the World Health Organisation's Disability Assessment Schedule (WHODAS 2.0) score of <25%.
WHODAS 2.0 measured using a trained, blinded assessor via telephone interview. The WHODAS scores are calculated using the sum of the six domain scores. These domain scores are then converted to a metric score ranging from 0 to 100 (where 0= no disability; 100= full disability)
At 6 months from study enrolment
Secondary Outcomes (14)
Number of participants with adverse events including major bleeding up to 28 days after ECMO, infection, thrombosis (in the ECMO cannulae or in the patient) and limb ischaemia
Up to 28 days after ECMO initiation
Healthcare utilization - caseload per centre
Up to 12 months from study enrolment
Healthcare utilization - ECMO initiation timing
Up to 12 months from study enrolment
Healthcare utilization - number of staff members required to manage ECMO
Up to 12 months from study enrolment
Healthcare utilization - hospital length of stay
Up to 12 months from study enrolment
- +9 more secondary outcomes
Eligibility Criteria
Patients admitted to hospitals with a primary diagnosis of acute heart failure, respiratory failure or cardiac arrest and received ECMO at participating ECMO centres.
You may qualify if:
- Patients admitted to adult hospitals and receive ECMO in Australia and New Zealand
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Australian and New Zealand Intensive Care Research Centrelead
- National Health and Medical Research Council, Australiacollaborator
- Extracorporeal Life Support Organizationcollaborator
- National Heart Foundation, Australiacollaborator
- The Alfredcollaborator
- Barwon Healthcollaborator
- Fiona Stanley Hospitalcollaborator
- The Prince Charles Hospitalcollaborator
- Royal Prince Alfred Hospital, Sydney, Australiacollaborator
- St Vincent's Hospital, Sydneycollaborator
Study Sites (29)
Canberra Hospital
Canberra, Australian Capital Territory, 2605, Australia
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
John Hunter Hospital
Newcastle, New South Wales, 2305, Australia
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
Prince of Wales Hospital
Sydney, New South Wales, 2031, Australia
St George Hospital
Sydney, New South Wales, 2217, Australia
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Royal Brisbane and Women's Hospital
Brisbane, Queensland, 4029, Australia
Princess Alexandra Hospital
Brisbane, Queensland, 4102, Australia
Prince Charles Hospital
Chermside, Queensland, 4032, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Sunshine Coast University Hospital
Sunshine Coast, Queensland, 4575, Australia
Townsville Hospital
Townsville, Queensland, 4814, Australia
Royal Adelaide Hosptial
Adelaide, South Australia, 5000, Australia
Flinders Medical Centre
Adelaide, South Australia, 5042, Australia
Launceston General Hospital
Launceston, Tasmania, 7250, Australia
Box Hill Hospital
Box Hill, Victoria, 3128, Australia
Monash Medical Centre
Clayton, Victoria, 3168, Australia
University Hospital Geelong
Geelong, Victoria, Australia
Austin Health
Heidelberg, Victoria, 3084, Australia
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
St Vincent's Hospital Melbourne
Melbourne, Victoria, 3065, Australia
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
Epworth Hospital
Richmond, Victoria, Australia
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
Fiona Stanley Hospital
Perth, Western Australia, 6150, Australia
Auckland City hospital
Auckland, 1023, New Zealand
Related Publications (5)
Hodgson CL, Higgins AM, Bailey MJ, Anderson S, Bernard S, Fulcher BJ, Koe D, Linke NJ, Board JV, Brodie D, Buhr H, Burrell AJC, Cooper DJ, Fan E, Fraser JF, Gattas DJ, Hopper IK, Huckson S, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Sheldrake J, Reddi BAJ, Stub D, Trapani TV, Udy AA, Serpa Neto A; EXCEL Study Investigators on behalf of the International ECMO Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. Lancet Respir Med. 2022 Nov;10(11):1038-1048. doi: 10.1016/S2213-2600(22)00248-X. Epub 2022 Sep 26.
PMID: 36174613RESULTFulcher BJ, Nicholson AJ, Linke NJ, Berkovic D, Hodgson CL; EXCEL Study Investigators and the International ECMO Network. The perceived barriers and facilitators to implementation of ECMO services in acute hospitals. Intensive Care Med. 2020 Nov;46(11):2115-2117. doi: 10.1007/s00134-020-06187-z. Epub 2020 Jul 23. No abstract available.
PMID: 32705292RESULTLinke NJ, Fulcher BJ, Engeler DM, Anderson S, Bailey MJ, Bernard S, Board JV, Brodie D, Buhr H, Burrell AJC, Cooper DJ, Fan E, Fraser JF, Gattas DJ, Higgins AM, Hopper IK, Huckson S, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Sheldrake J, Reddi BAJ, Stub D, Trapani TV, Udy AA, Hodgson CL; EXCEL Investigators. A survey of extracorporeal membrane oxygenation practice in 23 Australian adult intensive care units. Crit Care Resusc. 2020 Jun;22(2):166-170. doi: 10.51893/2020.2.sur7. No abstract available.
PMID: 32389109RESULTBrown A, Dennis M, Rattan N, Nanjayya V, Burrell A, Serpa Neto A, Hodgson C; EXCEL (a Comprehensive Binational Registry on the Treatment and Outcomes of Patients Requiring Extracorporeal Membrane Oxygenation [ECMO]) Study Investigators and the International ECMO Network. Neurologic Complications During Venoarterial Extracorporeal Membrane Oxygenation and Their Implications for 6-Month Patient-Centered Outcomes. Crit Care Med. 2026 Jan 1;54(1):175-186. doi: 10.1097/CCM.0000000000006938. Epub 2025 Nov 10.
PMID: 41212045DERIVEDSerpa Neto A, Higgins AM, Bailey MJ, Anderson S, Bernard S, Fulcher BJ, Jones A, Linke NJ, Board JV, Brodie D, Buhr H, Burrell AJC, Cooper DJ, Fan E, Fraser JF, Gattas DJ, Hopper IK, Huckson S, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Dicker C, Reddi BAJ, Stub D, Trapani TV, Udy AA, Hodgson CL; EXCEL Study Investigators on behalf of the International ECMO Network (ECMONet). Long-Term Functional Outcomes in the First 12 Months After VA-ECMO in Adult Patients: A Prospective, Multicenter Study. Circ Heart Fail. 2025 Jun;18(6):e012476. doi: 10.1161/CIRCHEARTFAILURE.124.012476. Epub 2025 Apr 29.
PMID: 40298907DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Carol L Hodgson, PhD
Australian and New Zealand Intensive Care Research Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2018
First Posted
January 4, 2019
Study Start
February 1, 2019
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
September 15, 2023
Record last verified: 2023-09